This information—including product information—is intended only for residents of the United States.
When 2021 rolls around, the company is expecting it to be neutral.
Most Active Tweeters for ARRY No tweets found Recent Tweets for ARRY 1125 N. Charles St, Baltimore, MD 21201.
2020 InvestorPlace Media, LLC.
Array common stock will cease to be traded on the Nasdaq Global Market. In connection with the merger, all Array shares not validly tendered (other than shares held by Array, Pfizer, their respective subsidiaries and shareholders of Array who have perfected their statutory appraisal rights) have been cancelled and converted into the right to receive the same $48 in cash (without interest and less any applicable withholding taxes) as will be paid for all Array shares that were validly tendered and not validly withdrawn. Following its acceptance of the tendered shares, Pfizer completed its acquisition of Array through a second step merger of Arlington Acquisition Sub Inc. with and into Array. As per the press release on the link below, the stock has now been delisted which means I cannot sell them, and if … Apologies if this is a dumb question but I am new to this. Sorry, you need to enable JavaScript to visit this website. Pfizer Inc. agreed to buy Array BioPharma Inc. for $10.64 billion in cash, as one of the world’s biggest pharmaceutical companies seeks to expand its cancer lineup with targeted therapies. This has the offer from Pfizer sitting at roughly 62% above the stock’s closing price on Friday.The recent Array BioPharma news will have the company joining Pfizer through a subsidiary. Computershare Trust Company, N.A., the depository and paying agent for the tender offer, has advised Pfizer that as of the tender offer expiration, 171,905,358 shares of Array common stock were validly tendered, representing approximately 77.0% of the shares outstanding. If you have an ad-blocker enabled you may be blocked from proceeding. Check out our ARRY stock analysis, current ARRY quote, charts, and historical prices for Array Biopharma Inc stock Copyright © If all goes well, the two companies are expecting the deal to close in the ARRY stock was up 55% and PFE stock was down slightly as of noon Monday.Article printed from InvestorPlace Media, https://investorplace.com/2019/06/array-biopharma-news-boosts-arry-stock/.Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Pfizer Completes Acquisition of Array Biopharma quotes delayed at least 15 minutes, all others at least 20 minutes. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal
We routinely post information that may be important to investors on our website at Copyright © 2002-2020 Pfizer Inc. All rights reserved.
When Dell's buyout talks began in the summer and fall of 2012,shares traded below $10.
Attunity stock soared Thursday after the data analytics company said it agreed to be acquired and taken private in a $560 million all-cash deal. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.
Brush has suggested INCY, SRPT, NBIX, ARRY, EXEL and GBT in his stock newsletter, Brush Up on Stocks. 1125 N. Charles St, Baltimore, MD 21201.
Once the deal is complete, a second-step merger will be used to require the remaining shares.Pfizer already outlines how it expects the deal to dilute its earnings per share over the next few years. For information on 2019 financial guidance, please see the press release for For additional background on the acquisition, please read the announcement press release At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Pfizer expects the transaction to be dilutive to Pfizer’s Adjusted Diluted EPS by $0.04 in 2019, $0.04 -$0.05 in 2020, neutral in 2021 and accretive beginning in 2022, with additional accretion and growth anticipated thereafter. “Combined with Pfizer’s leading research and development capabilities, today’s announcement strengthens our potential to translate advanced science and technologies into the breakthroughs that change patients’ lives.”As Array’s colleagues become part of Pfizer, the company plans to maintain Array’s operations in Cambridge, Massachusetts and Morrisville, North Carolina, as well as Boulder, Colorado, which becomes part of Pfizer’s Oncology Research & Development network in addition to La Jolla, California and Pearl River, New York.The tender offer for all of the outstanding shares of Array expired at 6:01 p.m., Eastern Time, on July 29, 2019. So the $13.50-per-shareoffer to take the company private represents nearly a 40% premium.
This includes dropping earnings per share between 4 cents and 5 cents in 2019.